|
Federal
Register Notices > Notices
of Application - 2005 > American Radiolabeled Chemicals, Inc.
FR Doc E5-6609 [Federal Register: November 29, 2005 (Volume 70, Number
228)] [Notices] [Page 71558] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29no05-94]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section
1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is
notice that on March 3, 2005, American Radiolabeled Chemicals, Inc., 101 Arc
Drive, St. Louis, Missouri 63146, made application by renewal to the Drug
Enforcement Administration (DEA) for registration as a bulk manufacturer of
the basic classes of controlled substances listed in Schedules I and II:
| Drug |
Schedule |
| Gamma hydroxybutyric acid (2010) |
I |
| Dimethyltryptamine (7435) |
I |
| Dihydromorphine (9145) |
I |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| Lysergic acid diethylamide (7315) |
II |
| Phencyclidine (7471) |
II |
| Phenylacetone (8501) |
II |
| Cocaine (9041) |
II |
| Codeine (9050) |
II |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Benzoylecgonine (9180) |
II |
| Ecgonine (9180) |
II |
| Meperidine (9230) |
II |
| Metazocine (9240) |
II |
| Morphine (9300) |
II |
| Thebaine (9333) |
II |
| Oxymorphone (9652) |
II |
The company plans to manufacture in bulk, small quantities of the listed
controlled substances as radiolabeled compounds.
Any other such applicant and any person who is presently registered with
DEA to manufacture such a substance may file comments or objections to the
issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail may be
addressed, in quintuplicate, to the Acting Deputy Assistant Administrator,
Office of Diversion Control, Drug Enforcement Administration, Washington, DC
20537, Attention: DEA Federal Register Representative, Liaison and Policy
Section (ODL); or any being sent via express mail should be sent to DEA
Headquarters, Attention: DEA Federal Register Representative/ODL, 2401
Jefferson Davis Highway, Alexandria, Virginia 22301; and must be filed no
later than January 30, 2006.
Joseph T. Rannazzisi,
Acting Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration.
[FR Doc. E5-6609 Filed 11-28-05; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|